_1777370220974_847775619.png&w=64&q=75){kind=small}
Experimental mRNA vaccine reduces melanoma relapse risk
A personalized mRNA cancer vaccine for melanoma showed promising results in a late-stage clinical trial, generating excitement among oncologists and the public before detailed efficacy data was released.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)